Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation

Clinical Cancer Research

Volumn 9, Issue 8, 2003, Pages 3004-3011

  Waguri, Nobuo ^a   Suda, Takeshi ^a   Nomoto, Minoru ^a   Kawai, Hirokazu ^a   Mita, Yusaku ^a   Kuroiwa, Takashi ^a   Igarashi, Masato ^a   Kobayashi, Makoto ^a   Fukuhara, Yasuo ^a   Aoyagi, Yutaka ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA ACTIN; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CATALYSIS; CHRONIC LIVER DISEASE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANTIGENS, CD45; BLOOD CELL COUNT; CARCINOMA, HEPATOCELLULAR; CELL SEPARATION; DNA-BINDING PROTEINS; FEMALE; HELA CELLS; HEPATOCYTES; HUMANS; IMMUNOMAGNETIC SEPARATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TELOMERASE;

EID: 12444255162     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Solbiati, L., and Gazelle, G. S. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology, 210: 655-661, 1999.
2. Curley, S. A., Izzo, F., Ellis, L. M., Nicolas, V. J., and Vallone, P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann. Surg., 232: 381-391, 2000.
3. Ringe, B., Wittekind, C., Bechstein, W. O., Bunzendahl, H., and Pichlmayr, R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann. Surg., 209: 88-98, 1989.
4. Harbeck, N., Untch, M., Pache, L., and Elermann, W. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br. J. Cancer, 69: 566-571, 1994.
5. Hardingham, J. E., Hewett, P. J., Sage, R. E., Finch, J. L., Nuttall, J. D., Kotasek, D., and Dobrovic, A. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int. J. Cancer, 89: 8-13, 2000.
6. Belghiti, J., Panis, Y., Farges, O., Benhamou, J. P., and Fekete, F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann. Surg., 214: 114-117, 1991.
7. Yamanaka, N., Okamoto, E., Fujihara, S., Kato, T., Fujimoto, J., Oriyama, T., Mitsunobu, M., Toyosaka, A., Uematsu, K., and Yamamoto, K. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? Cancer (Phila.), 70: 2263-2267, 1992.
8. Schlitt, H. J., Neipp, M., Weimann, A., Oldhafer, K. J., Schmoll, E., Boeker, K., Nashan, B., Kubicka, S., Maschek, H., Tusch, G., Raab, R., Ringe, B., Manns, M. P., and Pichlmayr, R. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J. Clin. Oncol., 17: 324-331, 1999.
9. Matsumura, M., Niwa, Y., Hikiba, Y., Okano, K., Kato, N., Shiina, S., Shiratori, Y., and Omata, M. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (α-fetoprotein mRNA) in blood. Biochem. Biophys. Res. Commun., 207: 813-818, 1995.
10. Matsumura, M., Niwa, Y., Kato, N., Komatsu, Y., Shiina, S., Kawabe, T., Kawase, T., Toyoshima, H. Ihori, M., Shiratori, Y., and Omata, M. Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology, 20: 1418-1425, 1994.
11. Komeda, T., Fukuda, Y., Sando, T., Kita, R., Furukawa, M., Nishida, N., Amenomori, M., and Nakao, K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer (Phila.), 75: 2214-2219, 1995.
12. Funaki, N. O., Tanaka, J., Seto, S. I., Kasamatsu, T., Kaido, T., and Imamura, M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology, 25: 564-568, 1997.
13. Louha, M., Poussin, K., Ganne, N., Zylberberg, H., Nalpas, B., Nicolet, J., Capron, F., Soubrane, O., Vons, C., Beaugrand, M., Berthelot, P., Franco, D., Trinchet J. C., Brechot, C., and Paterlini, P. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology, 26: 998-1005, 1997.
14. Wong, I. H., Lau, W. Y., Leung, T., Yeo, W., and Johnson, P. J. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin. Cancer Res., 5: 4021-4027, 1999.
15. Jiang, S. Y., Shyu, R. Y., Huang, M. F., Tang, H. S., Young, T. H., Roffler, S. R., Chiou, Y. S., and Yeh, M. Y. Detection of α-fetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis. Br. J. Cancer, 75: 928-933, 1997.
16. Lemoine, A., Le Bricon, T., Salvucci, M., Azoulay, D., Pham, P., Raccuia, J., Bismuth, H., and Debuire, B. Prospective evaluation of circulating hepatocytes by α-fetoprotein mRNA in humans during liver surgery. Ann. Surg., 226: 43-50, 1997.
17. Blackburn, E. H., and Greider, C. W. Telomeres. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1995.
18. Morin, G. B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59: 521-529, 1989.
19. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash. DC), 266: 2011-2015, 1994.
20. Shay, J. W., and Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer, 33: 787-791, 1997.
21. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90: 785-795, 1997.
22. Nakayama, J., Tahara, H., Tahara, E., Saito, M., Ito, K., Nakamura, H., Nakanishi, T., Tahara, E., Ide, T., and Ishikawa, F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet., 18: 65-68, 1998.
23. Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., and Yamakido, M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol., 155: 3711-3715, 1995.
24. Seki, K., Suda, T., Aoyagi, Y., Sugawara, S., Natsui, M., Motoyama, H., Shirai, Y., Sekine, T., Kawai, H., Mita, Y., Waguri, N., Kuroiwa, T., Igarashi, M., and Asakura, H. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification. Clin. Cancer Res., 7: 1976-1981, 2001.
25. Guadagni, F., Kantor, J., Aloe, S., Carone, M. D., Spila, A., D'Alessandro, R., Abbolito, M. R., Cosimelli, M., Graziano, F., Carboni, F., Carlini, S., Perri, P., Sciarretta, F., Greiner, J. W., Kashmiri, S. V., Steinberg, S. M., Roselli, M., and Schlom, J. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Cancer Res., 61: 2523-2532, 2001.
26. Berois, N., Varangot, M., Aizen, B., Estrugo, R., Zarantonelli, L., Fernandez, P., Krygier, G., Simonet, F., Barrios, E., Muse, I., and Osinaga, E. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR. Eur. J. Cancer, 36: 717-723, 2000.
27. Kawakami, M., Okaneya, T., Furihata, K., Nishizawa, O., and Katsuyama, T. Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2. Cancer Res., 57: 4167-4170, 1997.
28. American Liver Tumor Study Group. A Randomized Prospective Multi-institutional Trial of Orthotopic Liver Transplantation or Partial Hepatic Resection with or without Adjuvant Chemotherapy of Hepatocellular Carcinoma. Investigator Booklet and Protocol, Basel: Switzerland, KargarN, 1998.
29. Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., and Gennari, L. Liver transplantation for the treatment of small hepatocellular carcinoma. N. Engl. J. Med., 334: 693-699, 1996.
30. Latza, U., Niedobitek, G., Schwarting, R., Nekarda, H., and Stein, H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J. Clin. Pathol., 43: 213-219, 1990.
31. Wick, M., Zubov, D., and Hagen, G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene (Amst.), 232: 97-106, 1999.
32. Raff, T., van der Giet, M., Endemann, D., Wiederholt, T., and Paul, M. Design and testing of β-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques, 23: 456-460, 1997.
33. Beckwith, M., Longo, D. L., O'Connell, C. D., Moratz, C. M., and Urba, W. J. Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines. J. Natl. Cancer Inst. (Bethesda), 82: 501-509, 1990.
34. Kotoula, V., Hytiroglow, P., Pyrpasopoulou, A., Saxena, R., Thung, S. N., and Papadimitriou, C. S. Expression of human telomerase transcriptase in regenerative and precancerous lesions of cirrhotic livers. Liver, 22: 57-69, 2002.
35. Harada, K., Yasoshima, M., Ozaki, S., Sanzen, T., and Nakanuma, Y. PCR and in situ hybridization of telomerase subunits in human non-neoplastic livers. J. Pathol., 193: 210-217, 2001.
36. Kawakami, Y., Kitamoto, M., Nakanishi, T., Yasui, W., Tahara, E., Nakayama, J., Ishikawa, F., Tahara, H., Ide, T., and Kajiyama, G. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues. Oncogene, 19: 3888-3893, 2000.
37. Soria, J. C., Gauthier, L. R., Raymond, E., Granotier, C., Morat, L., Armand, J. P., Boussin, F. D., and Sabatier, L. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin. Cancer Res., 5: 971-975, 1999.
38. Gauthier, L. R., Granotier, C., Soria, J. C., Faivre, S., Boige, V., Raymond, E., and Boussin, F. D. Detection of circulating carcinoma cells by telomerase activity. Br. J. Cancer, 84: 631-635, 2001.
39. Hardingham, J. E., Kotasek, D., Farmer, B., Butler, R. N., Mi, J. X., Sage, R. E., and Dobrovic, A. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res., 53: 3455-3458, 1993.
40. Shibata, K., Mori, M., Kitano, S., and Akiyoshi, T. Detection of ras gene mutations in peripheral blood of carcinoma patients using CD45 immunomagnetic separation and nested mutant allele specific amplification. Int. J. Oncol., 12: 1333-1338, 1998.
41. Tatsuma, T., Goto, S., Kitano, S., Lin, Y. C., Lee, C. M., and Chen, C. L. Telomerase activity in peripheral blood for diagnosis of hepatoma. J. Gastroenterol. Hepatol., 15: 1064-1070, 2000.
42. Wennerberg, A. E., Nalesnik, M. A., and Coleman, W. B. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am. J. Pathol., 143: 1050-1054, 1993.
43. International Union Against Cancer (UICC). TNM classification of malignant tumours, 5th ed. In: I. H. Sobin and C. H. Wittekind (eds.), pp. 74-77. New York: Wiley-Liss, 1997.
44. Figueras, J., Jaurrieta, E., Valis, C., Benasco, C., Rafecas, A., Xiol, X., Fabregat, J., Casanovas, T., Torras, J., Baliellas, C., Ibanez, L., Moreno, P., and Casaiset, L. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology, 25: 1485-1489, 1997.
45. Llovet, J. M., Bruix, J., Fuster, J., Castells, A., Garcia-Valdecasas, J. C., Grande, L., Franca, A., Bru, C., Navasa, M., Ayuso, M. C., Sole, M., Real, M. I., Vilana, R., Rimola, A., Visa, J., and Rodes, J. Liver transplantation for small hepatocellular carcinoma: the Tumor-Node-Metastasis classification does not have prognostic power. Hepatology, 27: 1572-1577, 1998.
46. Toyosaka, A., Okamoto, E., Mitsunobu, M., Oriyama, T., Nakao, N., and Miura, K. Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel. Am. J. Gastroenterol., 91: 1610-1615, 1996.